Rani Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Business Updates
March 16 2023 - 4:05PM
Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”)
(Nasdaq: RANI), a clinical-stage biotherapeutics company focused on
the oral delivery of biologics and drugs, today announced that it
plans to release financial results for the fourth quarter and full
year ended December 31, 2022 on Wednesday, March 22 after the close
of trading. Rani’s management team will host a conference call and
webcast beginning at 4:30 p.m. ET.
To access the call by phone, please use this
registration link, and you will be provided with dial in details.
To avoid delays, we encourage participants to dial into the
conference call fifteen minutes ahead of the scheduled start time.
After the live webcast, the event will be archived for 90 days in
the Investor Relations section of Rani’s website at Events &
Presentations.
Rani Therapeutics
Rani Therapeutics is a clinical-stage
biotherapeutics company focused on advancing technologies to enable
the development of orally administered biologics and drugs. Rani
has developed the RaniPill™ capsules, which are a novel,
proprietary and patented platform technology, intended to replace
subcutaneous injection or intravenous infusion of biologics and
drugs with oral dosing. Rani has successfully conducted several
preclinical and clinical studies to evaluate safety, tolerability
and bioavailability using RaniPill™ capsules. For more
information, visit ranitherapeutics.com.
Investor Contact:
investors@ranitherapeutics.com
Media Contact:
media@ranitherapeutics.com
Rani Therapeutics (NASDAQ:RANI)
Historical Stock Chart
From Sep 2024 to Oct 2024
Rani Therapeutics (NASDAQ:RANI)
Historical Stock Chart
From Oct 2023 to Oct 2024